Topics
October 2014 | Cover Stories
Applications for Neuroprotection: The Next Therapeutic Category in Retina Medicine
Pravin U. Dugel, MD
November/December 2013 | Cover Stories
Enabling Personalized Medicine in the Management of Uveal Melanoma
The value of a repository for tumor biopsy specimens after gene expression profiling.
Thomas M. Aaberg Jr, MD
May 26, 2026
Outlook Therapeutics Wins FDA Appeal for Lytenava, Plans BLA Resubmission in June
May 22, 2026
Zeiss Appoints Bronwyn Brophy O’Connor as Head of Medical Technology Segment and CEO of Carl Zeiss Meditec
Ingenia Therapeutics Receives Approval to Advance IPO in Korea
May 21, 2026
Lexitas Pharma Services Acquires Erie Retina Research, CASExERIE, and Element Erie Assets
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
